Healy M L, Gibney J, Pentecost C, Croos P, Russell-Jones D L, Sönksen P H, Umpleby A M
Department of Diabetes and Endocrinology, Guy's, King's and St. Thomas' School of Medicine, St. Thomas Hospital, London SE1 7EH, United Kingdom.
J Clin Endocrinol Metab. 2006 Jan;91(1):320-7. doi: 10.1210/jc.2005-0916. Epub 2005 Nov 1.
Recombinant human-GH (r-hGH), in supraphysiological doses, is self-administered by athletes in the belief that it is performance enhancing.
The objective of this study was to determine whether r-hGH alters whole-body glucose and glycerol metabolism in endurance-trained athletes at rest and during and after exercise.
This was a 4-wk double-blind placebo-controlled trial.
This study was conducted at St. Thomas Hospital (London, UK).
Twelve endurance-trained male athletes were recruited and randomized to r-hGH (0.2 U/kg.d) (n = 6) or identical placebo (n = 6) for 4 wk. One (placebo group) withdrew after randomization.
Intervention was conducted by randomization to r-hGH (0.2 U/kg x d) or identical placebo for 4 wk.
Whole-body rates of appearance (Ra) of glucose and glycerol (an index of lipolysis) and rate of disappearance of glucose were measured using infusions of d-[6-6-2H2]glucose and 2H5-glycerol.
Plasma levels of glycerol and free fatty acids and glycerol Ra at rest and during and after exercise increased during r-hGH treatment (P < 0.05 vs. placebo). Glucose Ra and glucose rate of disappearance were greater after exercise during r-hGH treatment (P < 0.05 vs. placebo). Resting energy expenditure and fat oxidation were greater under resting conditions during r-hGH treatment (P < 0.05 vs. placebo).
r-hGH in endurance-trained athletes increased lipolysis and fatty acid availability at rest and during and after exercise. r-hGH increased glucose production and uptake rates after exercise. The relevance of these effects for athletic performance is not known.
重组人生长激素(r-hGH),在超生理剂量下,被运动员自行使用,他们认为其能提高运动表现。
本研究的目的是确定r-hGH是否会改变耐力训练运动员在静息状态、运动期间及运动后全身的葡萄糖和甘油代谢。
这是一项为期4周的双盲安慰剂对照试验。
本研究在英国伦敦圣托马斯医院进行。
招募了12名耐力训练的男性运动员,并随机分为r-hGH组(0.2 U/kg·d)(n = 6)或相同安慰剂组(n = 6),为期4周。其中1名(安慰剂组)在随机分组后退出。
通过随机分配接受r-hGH(0.2 U/kg×d)或相同安慰剂进行干预,为期4周。
使用d-[6-6-2H2]葡萄糖和2H5-甘油输注来测量葡萄糖和甘油(脂解指标)的全身出现率(Ra)以及葡萄糖的消失率。
在r-hGH治疗期间,静息状态、运动期间及运动后血浆甘油、游离脂肪酸水平和甘油Ra升高(与安慰剂相比,P < 0.05)。在r-hGH治疗期间,运动后葡萄糖Ra和葡萄糖消失率更高(与安慰剂相比,P < 0.05)。在r-hGH治疗期间,静息条件下静息能量消耗和脂肪氧化更高(与安慰剂相比,P < 0.05)。
耐力训练运动员使用r-hGH可增加静息状态、运动期间及运动后脂解和脂肪酸可用性。r-hGH增加运动后葡萄糖生成和摄取率。这些作用与运动表现的相关性尚不清楚。